AllianceBernstein’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.7M Sell
990,297
-103,360
-9% -$7.51M 0.02% 472
2025
Q4
$82.5M Sell
1,093,657
-325,475
-23% -$20.5M 0.03% 462
2025
Q3
$56.4M Buy
1,419,132
+30,983
+2% +$1.18M 0.02% 588
2025
Q2
$60.3M Buy
1,388,149
+107,199
+8% +$4.08M 0.02% 555
2025
Q1
$47.9M Sell
1,280,950
-74,235
-5% -$2.87M 0.02% 596
2024
Q4
$61.4M Buy
1,355,185
+160,822
+13% +$8.2M 0.02% 537
2024
Q3
$70.2M Buy
1,194,363
+62,093
+5% +$2.98M 0.02% 515
2024
Q2
$44.6M Buy
1,132,270
+387,152
+52% +$18.8M 0.02% 629
2024
Q1
$49.5M Buy
745,118
+734,478
+6,903% +$32.1M 0.02% 604
2023
Q4
$297K Buy
+10,640
New +$213K ﹤0.01% 2848

Other funds holding APGE